RCB Formula:
From: | To: |
Definition: This calculator computes the Residual Cancer Burden (RCB) index for breast cancer patients after neoadjuvant therapy.
Purpose: It helps oncologists quantify the amount of residual disease after preoperative treatment, which is important for prognosis and treatment planning.
The calculator uses the formula:
Where:
Explanation: The formula combines measures of residual invasive cancer, lymph node involvement, and treatment response into a single index.
Details: RCB provides standardized quantification of residual disease that correlates with long-term outcomes. Lower RCB values indicate better response to neoadjuvant therapy.
Tips: Enter all required parameters from pathology reports. Fraction invasive and viability should be between 0 and 1. Other measurements should be in millimeters.
Q1: What do different RCB values indicate?
A: RCB is categorized as: RCB-0 (pathologic complete response), RCB-I (minimal residual disease), RCB-II (moderate residual disease), RCB-III (extensive residual disease).
Q2: How is fraction invasive (f_inv) determined?
A: This is the proportion of invasive cancer cells in the residual tumor, typically assessed by pathologists.
Q3: What is viability (V) in this context?
A: Viability represents the proportion of tumor cells that appear viable (not destroyed by therapy), ranging from 0 (all cells dead) to 1 (all cells viable).
Q4: How accurate is the RCB index?
A: RCB has been validated in multiple studies and shows strong correlation with recurrence-free and overall survival.
Q5: Can this calculator be used for other cancers?
A: No, this specific formula is validated for breast cancer only. Other cancers may have different RCB calculations.